Concepedia

Peter Bouwman

PB

Statistics

Publications

36

Citations

4.5K

H-Index

27

Active since

1994

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Cancer Genomics Centre

University of Bern

CRUK/MRC Oxford Institute for Radiation Oncology

Peter Bouwman is an author at The Netherlands Cancer Institute specializing in molecular oncology, life sciences, and oncology.

ORCID

Publications per year

1994–2024

36

Publications

36

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

Constantia Pantelidou, Olmo Sonzogni, Mateus de Oliveira Taveira et al. · Cancer Discovery · 2019 · 720 citations · Full text

, , +17

REV7 counteracts DNA double-strand break resection and affects PARP inhibition

Guotai Xu, J. Ross Chapman, Inger Brandsma et al. · Nature · 2015 · 592 citations · Full text

, , +14

Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development

Laurens A. van Meeteren, Paula Ruurs, Catelijne Stortelers et al. · Molecular and Cellular Biology · 2006 · 532 citations · Full text

, , +15

BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival

Chiara Gorrini, Pegah S. Baniasadi, Isaac S. Harris et al. · The Journal of Experimental Medicine · 2013 · 284 citations · Full text

, , +14

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

Yifan Wang, Andrea J. Bernhardy, Cristina Cruz et al. · Cancer Research · 2016 · 271 citations · Full text

, , +16

1–5 of 36